013, 12:107. 34. Vinayak S, Alam MT, Sem R, Shah NK, Susanti AI, Lim P, Muth S, Maguire JD, Rogers WO, Fandeur T, Barnwell JW, Escalante AA, Wongsrichanalai C, Ariey F, Meshnick SR, Udhayakumar V: Various genetic backgrounds with the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in Cambodia. J Infect Dis 2010, 201:1551560. 35. Frank M, Lehners N, Mayengue PI, Gabor J, Dal-Bianco M, Kombila DU, Ngoma GM, Supan C, Lell B, Ntoumi F, Grobusch MP, Dietz K, Kremsner PG: A thirteen-year evaluation of Plasmodium falciparum populations reveals higher conservation from the mutant pfcrt haplotype despite the withdrawal of chloroquine from national remedy suggestions in Gabon. Malar J 2011, ten:304. 36. Menard S, Morlais I, Tahar R, Sayang C, Mayengue PI, Iriart X, Benoit-Vical F, Lemen B, Magnaval JF, Awono-Ambene P, Basco LK, Berry A: Molecular monitoring of Plasmodium falciparum drug susceptibility at the time on the introduction of artemisinin-based combination therapy in Yaounde, Cameroon: implications for the future.Tramiprosate Malar J 2012, 11:113. 37. Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G, Sasi P, Marsh K, Borrmann S, Mackinnon M, Nzila A: Chloroquine resistance before and following its withdrawal in Kenya. Malar J 2009, 8:106. 38. Thomsen TT, Ishengoma DS, Mmbando BP, Lusingu JP, Vestergaard LS, Theander TG, Lemnge MM, Bygbjerg IC, Alifrangis M: Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (pfmdr1) in Korogwe District in Tanzania just before and immediately after introduction of artemisinin-based mixture therapy.Desmosterol Am J Trop Med Hyg 2011, 85:97983.PMID:22943596 39. Lekana-Douki JB, Dinzouna Boutamba SD, Zatra R, Zang Edou SE, Ekomy H, Bisvigou U, Toure-Ndouo FS: Elevated prevalence with the Plasmodium falciparum pfmdr1 86N genotype among field isolates from Franceville,Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine. Infect Genet Evol 2011, 11:51217. 40. Cheeseman IH, Miller BA, Nair S, Nkhoma S, Tan A, Tan JC, Al Saai S, Phyo AP, Moo CL, Lwin KM, McGready R, Ashley E, Imwong M, Stepniewska K, Yi P, Dondorp AM, Mayxay M, Newton PN, White NJ, Nosten F, Ferdig MT, Anderson TJ: A significant genome area underlying artemisinin resistance in malaria. Science 2012, 336:792. 41. Park DJ, Lukens AK, Neafsey DE, Schaffner SF, Chang HH, Valim C, Ribacke U, Van Tyne D, Galinsky K, Galligan M, Becker JS, Ndiaye D, Mboup S, Wiegand RC, Hartl DL, Sabeti Pc, Wirth DF, Volkman SK: Sequence-based association and choice scans identify drug resistance loci in the Plasmodium falciparum malaria parasite. Proc Natl Acad Sci U S A 2012, 109(32):130523057. 42. Takala-Harrison S, Clark TG, Jacob CG, Cummings MP, Miotto O, Dondorp AM, Fukuda MM, Nosten F, Noedl H, Imwong M, Bethell D, Se Y, Lon C, Tyner SD, Saunders DL, Socheat D, Ariey F, Phyo AP, Starzengruber P, Fuehrer HP, Swoboda P, Stepniewska K, Flegg J, Arze C, Cerqueira GC, Silva JC, Ricklefs SM, Porcella SF, Stephens RM, Adams M, et al: Genetic loci linked to delayed clearance of Plasmodium falciparum following artemisinin therapy in Southeast Asia. Proc Natl Acad Sci U S A 2013, 110:24045.doi:ten.1186/1475-2875-12-441 Cite this article as: Van Tyne et al.: Changes in drug sensitivity and antimalarial drug resistance mutations over time amongst Plasmodium falciparum parasites in Senegal. Malaria Journal 2013 12:441.Submit your next manuscript to BioMed Central and take complete.